From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development-Reference-Cited by-同舟云学术

From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development

Published:2019-07 Issue:4 Volume:25 Page:245-253
ISSN:1540-336X
Container-title:The Cancer Journal
language:en
Short-container-title:Cancer J

Author:

Doroshow Deborah B.,Doroshow James H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference118 articles.

1. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer;N Engl J Med,2018

2. Lorlatinib in non–small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial;Lancet Oncol,2017

3. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;N Engl J Med,2008

4. BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships;Blood,2013

5. Making precision oncology the standard of care;Lancet Oncol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years;Cancers;2022-02-11

2. Artificial Intelligence for Precision Oncology;Advances in Experimental Medicine and Biology;2022

3. The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review;Clinical Therapeutics;2020-07

4. Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2020-06-05